The Pharmaceutical Division is the largest sector of Royal Group, accounting for 60% of the company’s total sales. Our products are manufactured in compliance with Current Good Manufacturing Practices (CGMP), adhering to World Health Organization (WHO) standards. Recognized and approved by various Health Ministries worldwide, we have successfully registered over 100 pharmaceutical products, including antibiotics, anti-inflammatory drugs, antimalarials, and more. These are available in multiple formulations such as tablets, capsules, granules, creams, oral liquids, and eye/ear drops.
Innovation in Packaging & Branding At Royal Group, we understand that packaging plays a crucial role in product marketing. Our in-house Research and Development (R&D) team, in collaboration with the Marketing Department, designs packaging solutions tailored to the specific market requirements of each country. While we ensure compliance with local regulations, we also adopt a globalized approach to create universally accepted packaging. All our brands are registered with trademark authorities both in the country of origin and in the markets where they are distributed. Additionally, we invest in strategic promotional activities, utilizing electronic and print media as well as direct engagement with healthcare professionals. Commitment to Innovation Our Research and Development Department is continuously working to expand our pharmaceutical portfolio by developing new, high-quality products that meet the evolving needs of the global healthcare market.